Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 226,052,337 papers from all fields of science
Search
Sign In
Create Free Account
factor V Leiden
Known as:
leiden factor v
, factor V G1691A
, FV Leiden
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
F5 gene
Factor V Leiden mutation
Broader (1)
Factor V
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Tamoxifen and the factor V Leiden mutation.
J. Cuzick
Journal of the National Cancer Institute
2010
Corpus ID: 8898408
Both tamoxifen and the factor V Leiden (FVL) mutations are wellestablished risk factors for thromboembolic events (TE). Tamoxifen…
Expand
Review
2009
Review
2009
Factor V 1691 G-A mutation distribution in a healthy Turkish population.
N. Ozbek
2009
Corpus ID: 220990903
The aim of this review was to compile published data on factor V 1691 G-A alteration in a healthy Turkish population and also to…
Expand
2008
2008
Should female relatives of factor V Leiden carriers be screened prior to oral contraceptive use?
Kenneth J. Smith
,
Brenna S Monsef
,
M. Ragni
Thrombosis and Haemostasis
2008
Corpus ID: 23257927
Summary Venous thromboembolism (VTE) is three-fold higher among FV Leiden (FVL) carriers receiving oral contraceptives (OCPs…
Expand
2007
2007
Petani Garam dalam Jeratan Kapitalisme: Analisis Kasus Petani Garam di Rembang, Jawa Tengah
Yety Rochwulaningsih
2007
Corpus ID: 154622319
The number of women in private and public organizations is increasing, but they are not reaching top management levels. Women are…
Expand
2006
2006
Alpha-galactosidase A deficiency leads to increased tissue fibrin deposition and thrombosis in mice homozygous for the factor V Leiden mutation.
Yue-chun Shen
,
P. Bodary
,
+5 authors
D. Eitzman
Stroke
2006
Corpus ID: 7293057
BACKGROUND Factor V Leiden (FVL) is a common genetic risk factor for vascular thrombosis in humans. Fabry disease, an X-linked…
Expand
2005
2005
Is factor V Leiden a risk factor for thrombotic microangiopathies without severe ADAMTS13 deficiency?
Soraya Krieg
,
J. Studt
,
I. Sulzer
,
B. Lämmle
,
J. Hovinga
Thrombosis and Haemostasis
2005
Corpus ID: 72320526
Summary About 60% of patients diagnosed with acute thrombotic thrombocytopenic purpura (TTP) display a severe ADAMTS13 deficiency…
Expand
2005
2005
Do People with HIV Get the Dental Care They Need
A. Leibowitz
,
I. Coulter
,
+20 authors
B. Freed
2005
Corpus ID: 53827941
s of all RAND Health publications and full text of many research documents can be found on the RAND Health web site at www.rand…
Expand
2004
2004
Symptomatic Thrombosis in Turkish Neonates
A. Gurgey
,
G. Tekinalp
,
A. Cinar
,
F. Cakmak
Journal of pediatric hematology/oncology
2004
Corpus ID: 42655916
Objective: To investigate the association of two common prothrombotic mutations, factor V G1691A (FV G1691A) and prothrombin…
Expand
Highly Cited
2003
Highly Cited
2003
Outcome of kidney transplantation in patients with inherited thrombophilia: data of a prospective study.
S. Heidenreich
,
R. Junker
,
+4 authors
U. Nowak-Göttl
Journal of the American Society of Nephrology
2003
Corpus ID: 39346371
Inherited prothrombotic risk factors predispose patients to thromboembolic events. In kidney transplant recipients, thrombophilia…
Expand
Highly Cited
2003
Highly Cited
2003
The factor V HR2 haplotype and the risk of venous thrombosis: a meta-analysis.
G. Castaman
,
E. Faioni
,
A. Tosetto
,
F. Bernardi
Haematologica
2003
Corpus ID: 2895865
BACKGROUND AND OBJECTIVES A complex haplotype of factor V gene (FV HR2) has been recently reported. FVHR2 possesses decreased co…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE